Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether an experimental drug called bevacizumab given
together with gemcitabine and docetaxel, a standard chemotherapy regimen for sarcoma, can
help sarcoma patients. This trial will examine what effects, good and/or bad the combination
of gemcitabine, docetaxel and bevacizumab has on sarcoma.